LemonAid Health was acquired by 23andMe in 2021 and briefly operated as part of a vertically integrated genetic-and-clinical platform. After 23andMe filed for Chapter 11 bankruptcy in 2025, the company’s assets — including LemonAid — were sold as part of the restructuring, and ownership changed hands (details below; verify the current status before relying on the service). The platform’s value proposition has always been radical price simplicity: flat, published fees for specific services with no insurance billing and prescriptions that can be delivered to the patient’s door. This LemonAid review covers what the platform treats, how its pricing generally works, what changed through the bankruptcy, and how LemonAid compares to PlushCare, Sesame, and Teladoc for cash-pay telehealth. Because pricing and service availability change, treat every dollar figure here as an example to confirm on the site rather than a quote.
How LemonAid works and who it serves
LemonAid is a cash-pay telehealth platform that focuses on a specific list of conditions rather than offering general primary care. You select a condition or service from the platform’s menu, complete a questionnaire, and pay a flat fee for a licensed clinician to review your case. Many evaluations are asynchronous and resolve within hours; some require a video visit. Approved prescriptions are sent to LemonAid’s mail-order pharmacy or to a pharmacy of your choice. Whether any medication is appropriate is a decision made by the reviewing clinician, not something the platform guarantees at checkout.
The model is closest to a curated formulary of common, well-protocoled conditions where asynchronous prescribing is clinically reasonable. LemonAid does not bill insurance for visits, though prescriptions sent to a retail pharmacy can run through your pharmacy benefits or a discount card. For broader direct-to-consumer telehealth context, see our telehealth guide.
LemonAid pricing in 2026
Flat-fee pricing is one of LemonAid’s biggest selling points: predictable charges rather than complex variable billing. As a general guide, a routine medical visit for issues such as UTI, sinus infection, or cold and flu symptoms has historically fallen in the roughly $25-$40 range. Mental health evaluations have started around $95 for an initial visit with lower-cost follow-ups. Birth control consultations have been priced around $25 with medication billed separately (often $15-$30 per month for generics). Hair loss, erectile dysfunction, and similar services have carried comparable flat fees plus the cost of any medication.
These numbers move over time, and the post-bankruptcy transition makes current pricing especially worth confirming. Check LemonAid’s site for the live fee for your specific service before booking. STI testing kits have ranged from roughly $50 to $200 depending on the panel. The value of the flat-fee structure is that you generally know the visit cost before you commit — but always verify the current amount rather than relying on last year’s figure. For cost context, see our healthcare costs guide.
What LemonAid treats well
LemonAid is competitively priced for the specific conditions it covers. A low flat-fee UTI consultation with same-day antibiotic prescribing (when clinically appropriate) can beat many urgent care copays. The platform’s narrow focus is arguably a clinical strength — limiting the menu to conditions suited to asynchronous care reduces the risk of prescribing for cases that really need an in-person exam.
The mail-order pharmacy integration is convenient for common prescriptions. LemonAid Pharmacy has shipped generic medications at competitive prices for routine conditions, sometimes beating GoodRx and sometimes not — it is worth comparing. For birth control specifically, the formulary is serviceable but narrower than dedicated platforms; see best telehealth for birth control for the wider field.
What LemonAid doesn’t do
LemonAid doesn’t try to be a primary care platform. There is no continuity-of-care assignment, no chronic disease management framework, no lab ordering for routine wellness, and no integrated specialist referrals. For complex chronic conditions or comprehensive care, LemonAid is the wrong tool, and you should use a primary care clinician instead.
The mental health offering is also limited. An initial evaluation for medication management can be reasonable, but the platform does not include integrated therapy, and its medication-management depth does not match dedicated psychiatric services. For more complex psychiatric needs, compare PlushCare and other dedicated platforms, and always route serious mental health concerns to a qualified clinician. LemonAid also does not offer comprehensive dermatology, weight-loss programs, or specialty care — patients needing those should look elsewhere.
The 23andMe acquisition, the 2025 bankruptcy, and what changed
23andMe acquired LemonAid in 2021 with the goal of integrating genetic information into clinical decision-making — for example, using pharmacogenomic data to inform medication selection. Some of that integration happened, particularly around antidepressant selection, where pharmacogenomic data has documented but limited clinical utility per CPIC guidelines. The broader vision was scaled back as 23andMe faced financial difficulties, a major data breach in 2023, and ultimately a Chapter 11 bankruptcy filing in 2025.
During the 2025 bankruptcy, 23andMe’s assets went through a court-supervised sale process. An early bid from Regeneron (reported around $256 million in May 2025) would have excluded LemonAid, but that deal did not proceed. After the auction was reopened, the nonprofit TTAM Research Institute — led by 23andMe co-founder Anne Wojcicki — acquired substantially all of 23andMe’s assets, including LemonAid Health, for about $305 million, with the purchase completed in July 2025. In short, LemonAid was not shut down in the bankruptcy; it changed hands as part of the whole-company asset sale. Because ownership transitions can affect services, pricing, and availability, confirm the platform’s current operating status and ownership directly before you rely on it.
For most patients, the day-to-day LemonAid experience has stayed broadly similar — flat-fee visits and pharmacy delivery for the same general condition list — but specific services can be added or discontinued during a transition. Patients who specifically want pharmacogenomic-informed prescribing should ask directly about the current state of that integration, since it has changed across multiple platform updates and ownership.
LemonAid for STI testing
LemonAid’s STI testing service is one of its more distinctive offerings. Patients can order at-home test kits for infections such as chlamydia, gonorrhea, syphilis, HIV, and hepatitis, with kits ranging from roughly $50 to $200 depending on panel breadth. Sample collection happens at home, kits are mailed to a lab, and results are reviewed by a clinician with treatment options if needed.
The model works well for asymptomatic screening and for patients in areas without easy access to STI clinics. For patients with active symptoms — particularly anything suggesting pelvic inflammatory disease or complications that require a physical exam — in-person care is more appropriate. The CDC STI treatment guidelines are the relevant clinical reference, and any positive result should be discussed with a clinician.
LemonAid vs PlushCare, Sesame, and Teladoc
Compared to PlushCare, LemonAid is generally cheaper for the conditions it covers but lacks primary care continuity. PlushCare is the better choice for ongoing care; LemonAid is the better choice for a one-off acute prescription. Compared to Sesame, the two are similar in price, but LemonAid has a tighter formulary while Sesame offers broader specialty access.
Compared to Teladoc, LemonAid is typically cheaper for cash-pay patients and similarly fast for straightforward issues. Insured patients should still default to Teladoc (or their own plan’s telehealth benefit) when it is covered, since that may cost little or nothing out of pocket. For uninsured patients, LemonAid and Sesame Care are among the cheaper paths to a same-day prescription when one is clinically appropriate.
Frequently Asked Questions
Is LemonAid still operating in 2026?
As of the most recent reporting, LemonAid continued to operate after being acquired by TTAM Research Institute in the 2025 bankruptcy process. Ownership transitions can change what is offered, so check the site directly and confirm service availability in your state before booking.
Does LemonAid accept insurance?
No. LemonAid is cash-pay for visits. Prescriptions sent to a retail pharmacy can run through your pharmacy benefits or a discount card, but the visit fees themselves are not insurance-billable.
Are LemonAid prescriptions same-day?
Many asynchronous evaluations are completed within hours, and prescriptions can be sent the same day to either LemonAid Pharmacy or a retail pharmacy when a clinician approves them. Mail-order delivery typically takes a few business days, so use a local pharmacy if you need medication immediately.
Does LemonAid prescribe controlled substances?
Generally no. LemonAid does not prescribe Schedule II controlled substances and is conservative about other controlled-substance prescribing under current DEA telemedicine rules. If you need that kind of care, see an in-person clinician.
How does LemonAid handle birth control?
Patients complete an intake covering medical history and contraindications, which a clinician reviews. Approved prescriptions can be sent to LemonAid Pharmacy for mail delivery or to a local pharmacy. The formulary covers common combination and progestin-only pills but is narrower than some dedicated contraception platforms.
The bottom line on LemonAid
LemonAid is a focused cash-pay telehealth platform that does a specific set of things competitively. Flat-fee pricing, fast turnaround, and integrated pharmacy delivery work well for its intended use cases — acute prescription needs, basic mental-health medication management, birth control, hair loss, ED, and STI testing — with any prescribing directed by a licensed clinician. For ongoing primary care or complex conditions, it is not designed to be the answer. Given the 2025 ownership change, confirm current pricing, services, and status before booking, and take any clinical decision to your clinician.
Disclaimer: This article is for general informational purposes only and is not medical advice, nor an endorsement of LemonAid. Prices, services, and ownership details change — the figures and status described here should be verified directly with LemonAid before you rely on them. Only a licensed clinician who reviews your case can decide whether a medication or test is appropriate for you. For urgent symptoms, seek in-person care or call 911.
Sources
- Reporting on 23andMe’s 2025 Chapter 11 bankruptcy and the TTAM Research Institute asset acquisition (including LemonAid Health)
- LemonAid Health (lemonaidhealth.com) — service menu and pricing pages (verify current details)
- CDC — Sexually Transmitted Infections Treatment Guidelines
- CPIC — Clinical Pharmacogenetics Implementation Consortium guidelines